ONCO
Onconetix Inc
NASDAQ: ONCO · HEALTHCARE · BIOTECHNOLOGY
$0.64
-8.57% today
Updated 2026-05-01
Market cap
$514220.00
P/E ratio
—
P/S ratio
0.63x
EPS (TTM)
$-82.80
Dividend yield
—
52W range
$1 – $54
Volume
9.4M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+2.5
Profitability
F6.7
Valuation
B4/9
Piotroski F-Score
Moderate
-6.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$9.00
+1317.32%
12-Month target
—
—
Intrinsic (DCF)
$5.05
Margin of safety
+63.37%
Price chart
X-Ray snapshot
Strengths
+ 63.37% below intrinsic value
+ Debt/equity 0.05x — low leverage
Risks
- Altman Z -6.89 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-3.09M
- Revenue declining -57.40% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $58465.00 | $2.52M | $815371.00 | $815370.00 |
| Net income | $-13.42M | $-37.41M | $-58.69M | $-14.03M | $5.67M |
| EPS | — | — | — | — | $-82.80 |
| Free cash flow | $-8.68M | $-13.64M | $-10.52M | $-9.68M | $-3.09M |
| Profit margin | — | -63,986.48% | -2,325.21% | -1,720.98% | — |
Peer comparison
Smart narrative
Onconetix Inc trades at $0.64. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -6.89, it sits in the distress. TTM revenue stands at $815370.00. Our DCF model estimates intrinsic value at $5.05.
Frequently asked questions
What is Onconetix Inc's stock price?
Onconetix Inc (ONCO) trades at $0.64.
Is Onconetix Inc overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell). DCF value $5.05.
What is the price target of Onconetix Inc (ONCO)?
The analyst target price is $9.00, representing +1317.3% upside from the current price of $0.64.
What is the intrinsic value of Onconetix Inc (ONCO)?
Based on our DCF model, intrinsic value is $5.05, a +63.4% margin of safety versus $0.64.
What is Onconetix Inc's revenue?
TTM revenue is $815370.00.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-6.89 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.63x
ROE-115.50%
Beta3.63
50D MA$2.27
200D MA$10.66
Shares out0.00B
Float0.00B
Short ratio—
Avg volume9.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—